Wedge Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wedge Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	435,650 -104,842	-19%	-$404K	0.03%	346
2026 Q1	$1.9M	Buy	+540,492	New	+$2.22M	0.04%	355
2025 Q1	–	Sell	-289,023	Closed	-$1.28M	–	526
2024 Q4	$1.28M	Sell	289,023 -25,820	-8%	-$105K	0.02%	388
2024 Q3	$1.3M	Buy	+314,843	New	+$1.69M	0.02%	388
2023 Q3	–	Sell	-248,755	Closed	-$2.65M	–	506
2023 Q2	$2.65M	Buy	248,755 +228,193	+1,110%	+$2.45M	0.04%	340
2023 Q1	$216K	Buy	20,562 +5,659	+38%	+$63.4K	﹤0.01%	398
2022 Q4	$185K	Sell	14,903 -86	-0.6%	-$976	﹤0.01%	406
2022 Q3	$155K	Hold	14,989	–	–	﹤0.01%	390
2022 Q2	$173K	Buy	14,989 +15	+0.1%	+$177	﹤0.01%	395
2022 Q1	$188K	Sell	14,974 -3,409	-19%	-$39.1K	﹤0.01%	408
2021 Q4	$214K	Buy	18,383 +3,182	+21%	+$39K	﹤0.01%	386
2021 Q3	$199K	Buy	15,201 +3,657	+32%	+$47.3K	﹤0.01%	387
2021 Q2	$149K	Sell	11,544 -1,793	-13%	-$20.5K	﹤0.01%	388
2021 Q1	$149K	Sell	13,337 -4,594	-26%	-$48.5K	﹤0.01%	516
2020 Q4	$204K	Buy	+17,931	New	+$196K	﹤0.01%	535

Other funds holding IRWD

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

RFG

Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wedge Capital Management's IRWD Position: Q2 2026 in Review

Wedge Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 19% in Q2 2026, selling an estimated $404K and leaving 435,650 shares worth $1.83M. The position accounts for 0.03% of the portfolio, ranked #346.

Wedge Capital Management first reported a position in IRWD in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.65M in Q2 2023. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Wedge Capital Management held 435,650 shares of Ironwood Pharmaceuticals worth $1.83M as of Q2 2026.
Wedge Capital Management sold 104,842 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $404K.
Ironwood Pharmaceuticals made up 0.03% of Wedge Capital Management's portfolio in Q2 2026, its #346 holding.
Wedge Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
Wedge Capital Management's Ironwood Pharmaceuticals position peaked at $2.65M in Q2 2023.
14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.